The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...

Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

The proportion of obese Indians has risen from 25 per cent in 2013 to 40 per cent in 2023, highlighting the need for ...

The use of GLP-1 drugs sparked the term "Ozempic shaming" to describe the negative perceptions faced by those who choose ...

Ozempic, approved for Type 2 diabetes, has gained fame for its weight-loss properties, especially among celebrities. Despite its rising popularity, ex ...

A new generation of weight loss drugs has helped some people lose significant amounts of weight and improve their health.

Retatrutide, an experimental drug by Eli Lilly, shows promising results in weight loss by targeting three hormones, ...

Interested in an oral alternative to Ozempic injections? You might be considering metformin, an FDA-approved type 2 diabetes ...